亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Efficient Biosynthesis of Natural Potent Anti-Malarial Drug (Yissum)

总结
Artemisinins, produced from the traditional Chinese medicinal herb Artemisia annua (sweet wormwood), are the only class of drugs against malaria to which there is no known resistance.
However, artemisinin levels in A. annua usually constitute only about 0.01% to 1% of the total dry weight of the plant, and since complete chemical synthesis of artemisinin is complex and inefficient, the drug is too expensive for most malaria sufferers in developing countries and is in short supply worldwide.
The World Health Organisation promotes the use of artemisinin for malaria treatment and has been heavily involved in aiding in the development of artemisinin-based anti-malaria drugs.Only demonstration of artemisinin production outside of host organism.
Authentic artemisinin accumulated in the engineered plants.
Genetically engineered tobacco is easily cultivated.
Efficient, low-cost system for producing artemisinin.
技术优势
Globally, 247 million clinical episodes of malaria are estimated to occur every year
Artemisinin-based combination therapy (ACT) has been recommended by WHO since 2001 as the first-line treatment for uncomplicated malaria
申请号码
United States patent filed (61/486,546
ID号码
6-2008-2099
国家/地区
以色列

欲了解更多信息,请点击 这里
移动设备